128 related articles for article (PubMed ID: 8629676)
21. [Post-transfusion hemochromatosis. Results of a study carried out in Blood Transfusion Centers. Analysis of 15 cases treated with subcutaneous perfusion of Desferal. Working group "Transfusion Techniques and Therapeutics"].
Jaulmes D; Quarre MC; Audat F; Gaonach MJ
Transfus Clin Biol; 1994; 1(1):55-64. PubMed ID: 8186855
[TBL] [Abstract][Full Text] [Related]
22. [Effect of desferrioxamine B and 2-(beta-aminoethoxy)cyclohexylaminetetraacetate in experimental hemochromatosis in rats and in primary hemochromatosis of man].
Bohne F; Lessmann J
Arzneimittelforschung; 1969 Jun; 19(6):944-7. PubMed ID: 5820039
[No Abstract] [Full Text] [Related]
23. [Intensifying iron chelating therapy with desferrioxamine using implantable venous access catheters (Port-A-Cath)].
de Montalembert M; Jan D; Clairicia M; Hannedouche T; Sidi D; Girot R
Arch Fr Pediatr; 1992 Mar; 49(3):159-63. PubMed ID: 1610270
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of primary idiopathic hemochromatosis and secondary hemosiderosis].
Strohmeyer G
Dtsch Med Wochenschr; 1974 Nov; 99(45):2295-9. PubMed ID: 4448138
[No Abstract] [Full Text] [Related]
25. Desferal therapy in iron storage disease.
Thompson RB; Owen DM; Bell WN
Am J Med Sci; 1967 Apr; 253(4):453-60. PubMed ID: 6021380
[No Abstract] [Full Text] [Related]
26. [First results of a new iron chelating agent in the treatment of post-transfusional hemochromatosis].
Giraud P; Orsini A; Giraud F; Pinsard N
Arch Fr Pediatr; 1965 Apr; 22(4):463-8. PubMed ID: 5826583
[No Abstract] [Full Text] [Related]
27. [Continuous subcutaneous desferrioxamine injection in primary idiopathic hemochromatosis with macrocytic anemia].
Schneider C; Richter H; Fischer JL; Larcher W
Internist (Berl); 1989 May; 30(5):335-7. PubMed ID: 2661477
[No Abstract] [Full Text] [Related]
28. [Mechanism of action of desferrioxamine].
Kaszewska-Jablońska I; Zielińska W
Wiad Lek; 1975 Jan; 28(2):89-96. PubMed ID: 1111247
[No Abstract] [Full Text] [Related]
29. Intraperitoneal deferoxamine therapy for iron overload in children undergoing CAPD.
Andreoli SP; Cohen M
Kidney Int; 1989 Jun; 35(6):1330-5. PubMed ID: 2770113
[TBL] [Abstract][Full Text] [Related]
30. Iron overload in congenital erythrocyte pyruvate kinase deficiency.
Salem HH; Van Der Weyden MB; Firkin BG
Med J Aust; 1980 May; 1(11):531-2. PubMed ID: 7393032
[TBL] [Abstract][Full Text] [Related]
31. Hyperpigmentation and secondary hemochromatosis: a novel treatment with extracorporeal chelation.
Held JL; Yankiver B; Kohn SR
J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):253-4. PubMed ID: 8432923
[No Abstract] [Full Text] [Related]
32. [Contribution to the problem of hemochromatosis].
Bruns W; Michaelis D; Takác A; Langsch HG
Dtsch Z Verdau Stoffwechselkr; 1966 Feb; 25(6):363-70. PubMed ID: 5998360
[No Abstract] [Full Text] [Related]
33. [Hemochromatosis and its modern treatment].
Böttger G
Z Gesamte Inn Med; 1967 Jun; 22(12):376-80. PubMed ID: 5593769
[No Abstract] [Full Text] [Related]
34. [Iron storage disease].
Heilmeyer L
Munch Med Wochenschr; 1967 Mar; 109(13):677-84. PubMed ID: 5631729
[No Abstract] [Full Text] [Related]
35. Idiopathic hemochromatosis: case report of a patient presenting with neurologic symptoms.
Sinclair WP; Afrooz N
J Am Geriatr Soc; 1977 Jul; 25(7):324-7. PubMed ID: 864179
[TBL] [Abstract][Full Text] [Related]
36. Cirrhosis with secondary siderosis or primary haemochromatosis.
Williams R
Proc R Soc Med; 1967 Dec; 60(12):1255-7. PubMed ID: 6066568
[No Abstract] [Full Text] [Related]
37. Treatment of iron storage disorders.
Halliday JW; Bassett ML
Drugs; 1980 Sep; 20(3):207-15. PubMed ID: 7428669
[No Abstract] [Full Text] [Related]
38. Efficacy of intramuscular and intraperitoneal deferoxamine for aluminum chelation.
Molitoris BA; Alfrey PS; Miller NL; Hasbargen JA; Kaehney WD; Alfrey AC; Smith BJ
Kidney Int; 1987 Apr; 31(4):986-91. PubMed ID: 3586503
[TBL] [Abstract][Full Text] [Related]
39. [Clinically isolated cardiac hemochromatosis treated with success by desferrioxamine].
Moretti G; Staeffen J; Galley P; Mulet M; Descamps F
J Med Bord; 1965 Dec; 142(12):1983-6. PubMed ID: 5855516
[No Abstract] [Full Text] [Related]
40. Treatment of primary hemochromatosis with deferoxamine.
Young N; Henry W; Nienhuis AW
JAMA; 1979 Mar; 241(11):1152-4. PubMed ID: 762769
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
